These data suggest that the anti-parallel NF-κB–SHP2 and STAT signaling pathways are competitively active in precancerous inflammatory liver tissues, but their activities are lost simultaneously upon transformation of liver cells during HCC development. This evidence concerns the gene NFKB1 and hepatocellular carcinoma.